Department of Ultrasound, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, China.
J Ultrasound Med. 2019 Nov;38(11):2811-2820. doi: 10.1002/jum.15008. Epub 2019 Apr 5.
This article reviews the clinical applications of Superb Microvascular Imaging (SMI; Canon Medical Systems, Otawara, Japan) in the liver, breast, thyroid, skeletal muscle, and carotid plaques. Diseases that are closely associated with angiogenesis can be diagnosed by SMI in a relatively early phase, and using SMI can prevent adverse reactions associated with the contrast agents used in contrast-enhanced ultrasound. Super Microvascular Imaging also shows particular value in grading disease activities and monitoring therapeutic responses. Although SMI has some limitations, such as a lack of clinical standards, it can add information to conventional ultrasound examinations and may become a noninvasive alternative to invasive diagnostic procedures for many clinical conditions.
本文综述了 Superb Microvascular Imaging(SMI;佳能医疗系统公司,日本鸟居)在肝脏、乳腺、甲状腺、骨骼肌和颈动脉斑块中的临床应用。SMI 可在相对较早阶段诊断与血管生成密切相关的疾病,并可预防与超声造影中使用的造影剂相关的不良反应。Super Microvascular Imaging 还在疾病活动分级和监测治疗反应方面具有特殊价值。虽然 SMI 存在一些局限性,如缺乏临床标准,但它可以为常规超声检查增加信息,并且可能成为许多临床情况下的非侵入性替代侵入性诊断程序。